:: Gulf Thoracic 2010 ::

Sponsors & Exhibitors

Click here to download sponsorship brochure

Platinum Sponsor

GlaxoSmithKline have a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines and products that help millions of people around the world.

We are one of the few pharmaceutical companies researching both medicines and vaccines for the World Health Organization’s three priority diseases – HIV/AIDS, tuberculosis and malaria, and are very proud to have developed some of the leading global medicines in these fields.

Headquartered in the UK and with operations based in the US, we are one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.

But being a leader brings responsibility. This means that we care about the impact that we have on the people and places touched by our mission to improve health around the world.

It also means that we must help developing countries where debilitating disease affects millions of people and access to life-changing medicines and vaccines is a problem. To meet this challenge, we are committed to providing discounted medicines where they are needed the most.

We produce medicines that treat six major disease areas – asthma, virus control, infections, mental health, diabetes and digestive conditions. In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer.

Every second...
we distribute more than 35 doses of vaccine
Every minute...
more than 1,100 prescriptions are written for GSK products
Every hour...
we spend more than £300,000 (US$562,000) to find new medicines
Every day...
more than 200 million people around the world use a GSK brand toothbrush or toothpaste
Every year...
our factories produce 9 billion Tums tablets, 6 billion Panadol tablets and 600 million tubes of toothpaste

Gold Sponsor

Silver Sponsor

Bronze Sponsor

Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion, founded in late 1997, is a leading player in innovative science related to the endothelium - the single layer of cells separating every blood vessel from the blood stream. Actelion's over 2'200 employees focus on the discovery, development and marketing of innovative drugs for significant unmet medical needs.

JULPHAR GULF PHARMACEUTICAL INDUSTRIES

Sine Gulf Pharmaceutical Industries (JULPHAR) has been established in 1980 as the first UAE Company specialized in pharmaceuticals’ manufacturing in the region, worked on strengthening its leading and distinguished role and adopted the method of renewal and innovation depending on the application of the highest quality standards and the highest international standards in all pharmaceutical manufacturing aspects.

And as a result of the company's commitment to strict quality and benefits of appropriate prices for its products, it has been able to have a distinct presence in more than 50 countries around the world.

And from its social and humanitarian responsibilities, in collaboration with many health, research and educational institutions, JULPHAR is sponsoring execution of health related projects/programs and participate in the training and contribute to a variety of sponsorships and Support the efforts of the State in the areas of relief aid.